Business Context and Reporting Period
This Form 8-K is a current report filed by Tharimmune, Inc. (trading symbol: THAR) on February 8, 2024. The registrant is a Delaware corporation and an emerging growth company headquartered in Bridgewater, New Jersey. The report addresses Item 8.01 (Other Events) regarding the company's capital structure as of the filing date.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The only quantitative data disclosed in this report relates to the company's equity capitalization.
- Common Stock Outstanding: 11,739,676 shares as of February 8, 2024.
- Par Value: $0.0001 per share.
Material Changes
The filing does not disclose material changes in financial performance or operations compared to prior periods. The report serves solely to update the record of outstanding shares.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, contingencies, or unusual items. The document is limited to the disclosure of share count under Item 8.01.
Investor Verification Checklist
- Verify the current share count of 11,739,676 against recent trading volumes and insider transaction reports.
- Confirm the company's status as an emerging growth company and its implications for financial reporting standards.
- Review subsequent filings for any changes in capital structure or financial performance not covered in this specific 8-K.